Journal
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Volume 48, Issue -, Pages 29-35Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2017.06.006
Keywords
omega-3 Polyunsaturated fatty acids (PUFAs); Docosahexaenoic acid (DHA); Colorectal cancer; Lipidomics; Epoxydocosapentaenoic acids (EDPs)
Funding
- USDA NIFA [2016-67017-24423]
- NIFA [810853, 2016-67017-24423] Funding Source: Federal RePORTER
Ask authors/readers for more resources
Many studies have shown that dietary intake of omega-3 polyunsaturated fatty acids (PUFAs) reduces the risks of colorectal cancer; however, the underlying mechanisms are not well understood. Here we used a LC-MS/MS-based lipidomics to explore the role of eicosanoid signaling in the anti-colorectal cancer effects of omega-3 PUFAs. Our results showed that dietary feeding of omega-3 PUFAs-rich diets suppressed growth of MC38 colorectal tumor, and modulated profiles of fatty acids and eicosanoid metabolites in C57BL/6 mice. Notably, we found that dietary feeding of omega-3 PUFAs significantly increased levels of epoxydocosapentaenoic acids (EDPs, metabolites of omega-3 PUFA produced by cytochrome P450 enzymes) in plasma and tumor tissue of the treated mice. We further showed that systematic treatment with EDPs (dose=0.5 mg/kg per day) suppressed MC38 tumor growth in mice, with reduced expressions of pro-oncogenic genes such as C-myc, Axing, and C-jun in tumor tissues. Together, these results support that formation of EDPs might contribute to the anti-colorectal cancer effects of omega-3 PUFAs. (C) 2017 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available